NRAS and metastatic melanoma: Studies have been conflicting to date; Fang et al. have shown data suggesting that BRAF and NRAS mutations are associated with increased failure of local control, and Jakob et al. have shown that NRAS mutation is associated with decreased survival in metastatic melanoma [8,13].